Developing exosome-based therapeutics for patients suffering from life-threatening cardiovascular diseases

• Moderated multiple thematic network events related to finance, entrepreneurship, and capital management.• Accelerated event promotion via dynamic social networking strategies.

• Scouting and due diligence for academic research projects, transforming them into viable start-up ventures within the regenerative medicine sector and developing a strategic deal-flow pipeline for potential follow-on investments by the FIRST Fund from BioGeneration Ventures.• Devising valorization strategies for regenerative treatments of complex diseases for addressing significant unmet medical needs

Business Developer for the Amsterdam UMC Heart Center• Drove industry contract negotiations to secure increases of 31% to 135% above initial budget proposals, adding a cumulative €350,000 to the baseline, which culminated in the successful execution of 20 industry contracts with a combined value of €2.0M.• Oversaw a portfolio comprising 49 varied projects with a collective contract value of €6.3M, guaranteeing optimal resource management, rigorous compliance with project schedules, and dynamic engagement with stakeholders to ensure seamless execution.• Expanded the partnership network by strategically profiling the expertise of principal investigators and aligning them with key industry- and health organizations, thereby broadening the reach and impact of the Amsterdam UMC Heart Center.• Provided strategic guidance to researchers on patentable inventions with commercial potential, thereby bolstering the organization's intellectual property portfolio.

Identified opportunities for market adaptation strategy for using extracellular vesicles as drug delivery vehicle